[Bronchodilating and cardiovascular actions of (-)-1-(3, 4, 5-trimethoxybenzyl)-5, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline hydrochloride (l-DTI) in the anesthetized dog (author's transl)].
D000818:Animals; D000959:Antihypertensive Agents; D001993:Bronchodilator Agents; D002302:Cardiac Output / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D007536:Isomerism; D007545:Isoproterenol / Q000494:pharmacology; D007546:Isoquinolines / Q000494:pharmacology*; D008297:Male; D014213:Tretoquinol / Q000494:pharmacology*; D014665:Vasodilator Agents
D000959:Antihypertensive Agents; D001993:Bronchodilator Agents; D007546:Isoquinolines; D014665:Vasodilator Agents; D014213:Tretoquinol; D007545:Isoproterenol